Clinic
Clarksville Health System, LLC
Clarksville Health System, LLC was paid $33.01M by Medicaid between Jan 2018 and Dec 2024, across 109 billing codes. Its largest line is 99283, emergency room visit (moderate) — 37% of everything it billed.
33Billing provider infoCLARKSVILLE HEALTH SYSTEM, LLC
CLARKSVILLE, TN 37040
CLARKSVILLE, TN 37040
33aNPI1285689794assigned 05/23/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$33.01M
24GClaims762,397
24DCodes billed109
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Tennessee
Rank by total paid#1 of 91
Median peer was paid$55K
This provider vs. median602×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 106,026 | $3.96M | |
| 2019 | 109,382 | $4.49M | |
| 2020 | 90,225 | $3.91M | |
| 2021 | 112,569 | $4.99M | |
| 2022 | 121,173 | $5.46M | |
| 2023 | 131,137 | $5.78M | |
| 2024incomplete | 91,885 | $4.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 37% | 89,130 | 82,015 | $12.06M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 61,841 | 55,586 | $10.91M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 18,463 | 15,836 | $3.94M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.0% | 13,617 | 12,741 | $1.32M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.1% | 26,154 | 24,295 | $690K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 19,697 | 16,704 | $460K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 77,536 | 67,927 | $262K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 532 | 427 | $259K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 991 | 849 | $235K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,485 | 1,187 | $216K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 18,407 | 16,716 | $191K |
| 80053 | Comprehensive metabolic panel | <1% | 62,425 | 55,021 | $184K |
97 more codes
| 71045 | Radiologic examination, chest; single view | <1% | 21,179 | $169K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 609 | $168K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 25,386 | $168K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 12,446 | $160K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 22,235 | $156K |
| 36415 | Collection of venous blood by venipuncture | <1% | 88,234 | $130K |
| 84484 | <1% | 17,824 | $121K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 5,248 | $112K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,131 | $105K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 3,245 | $105K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 366 | $87K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 19,666 | $84K |
| 97597 | <1% | 3,304 | $72K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,331 | $57K |
| G0378 | Hospital observation service, per hour | <1% | 443 | $56K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,022 | $55K |
| 83690 | <1% | 14,730 | $54K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,632 | $51K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,549 | $41K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,162 | $36K |
| 81001 | <1% | 41,322 | $32K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,321 | $29K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 339 | $22K |
| 84703 | <1% | 5,408 | $21K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,671 | $16K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 346 | $15K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,542 | $15K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 290 | $14K |
| 85610 | <1% | 7,194 | $12K | |
| 81025 | <1% | 4,663 | $11K | |
| 83735 | <1% | 4,056 | $10K | |
| 87400 | <1% | 1,642 | $10K | |
| 82077 | <1% | 1,685 | $9K | |
| 71250 | <1% | 274 | $9K | |
| 83605 | <1% | 1,764 | $9K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 69 | $8K |
| 85730 | <1% | 2,859 | $7K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 29 | $7K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 180 | $5K |
| 82550 | <1% | 1,490 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 13 | $3K |
| 80143 | <1% | 601 | $3K | |
| 82553 | <1% | 1,006 | $3K | |
| 80179 | <1% | 556 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 206 | $3K |
| 82248 | <1% | 1,230 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 671 | $2K |
| 87807 | <1% | 359 | $2K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 66 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,153 | $2K |
| 81003 | <1% | 2,632 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 101 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 101 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 25 | $1K |
| 83880 | <1% | 145 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 215 | $1K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $955.52 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 36 | $872.54 |
| 87040 | <1% | 120 | $797.56 | |
| 85379 | <1% | 75 | $716.45 | |
| 84702 | <1% | 68 | $607.32 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 25 | $461.89 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 81 | $438.21 |
| 93017 | <1% | 14 | $383.22 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 74 | $382.29 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 13 | $364.80 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 83 | $288.48 |
| 82962 | <1% | 249 | $269.27 | |
| 87088 | <1% | 99 | $268.48 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 13 | $198.72 |
| 82150 | <1% | 60 | $174.38 | |
| 87210 | <1% | 91 | $172.53 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 13 | $132.36 |
| 84145 | <1% | 31 | $119.08 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 15 | $114.08 |
| 87081 | <1% | 30 | $88.97 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 17 | $55.77 |
| 85027 | <1% | 29 | $54.65 | |
| 74018 | <1% | 13 | $53.32 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 39 | $49.64 |
| 73630 | <1% | 12 | $39.86 | |
| 94664 | <1% | 13 | $32.56 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,673 | $18.73 |
| 86140 | <1% | 14 | $17.22 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 41 | $10.76 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 28 | $3.65 |
| J2704 | Injection, propofol, 10 mg | 0% | 4,049 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 606 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 193 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 47 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 139 | $0.00 |
| 88304 | 0% | 14 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 182 | $0.00 |
| 88312 | 0% | 795 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 19 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 15 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOORE, CECELIA (AUTHORIZED OFFICIAL/TREASURER)
| Provider | Location | Paid |
|---|---|---|
| Vanderbilt University Medical Center | Lebanon, TN | $8.03M |
| Vanderbilt Health Clinicians, LLC | Nashville, TN | $8K |
| Vanderbilt University Medical Center | Lebanon, TN | $377.69 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.